NeuroSense Therapeutics Ltd. (NRSNW) Stock Price & Growth Analysis

Quote Panel

Updated October 28, 2024

1W 13.33 % 1M 36.07 % 3M 46.54 % 1Y 98.44 %

Key Metrics

Market Cap
23.75M
Shares Outstanding
129.81M
Share in Float
96.98M
Dividende
0

Earning Date
No Data
Price Target
0.1905
Average Volume
Beta
1.555

Range
0.1905-0.1925
Industry
Biotechnology
Website
https://www.neurosense-tx.com
Sector
Healthcare

Fundamentals

Infinityx

P/E Ratio

0.00x

P/S Ratio

-14.31x

P/B Ratio

-0.0

Debt/Equity

0.0%

Net Margin

$-0.9

EPS

How NRSNW compares to sector?

P/E Ratio

Relative Strength

NRSNW

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q1.22

N/A

NA
vs NA

Q2.22

N/A

NA
vs NA

Q3.22

N/A

NA
vs NA

Q4.22

N/A

NA
vs NA

Q1.23

N/A

NA
vs NA

Q2.23

N/A

NA
vs NA

Q3.23

N/A

NA
vs NA

Q4.23

N/A

NA
vs NA

Q1.24

N/A

NA
vs NA

Q2.24

N/A

NA
vs NA

Sales Growth

YoY

Current

Estimates

Q1.22

NA vs NA

Q2.22

NA vs NA

Q3.22

NA vs NA

Q4.22

NA vs NA

Q1.23

NA vs NA

Q2.23

NA vs NA

Q3.23

NA vs NA

Q4.23

NA vs NA

Q1.24

NA vs NA

Q2.24

NA vs NA

Return on Equity

QoQ

Q3.22

-34%

-0.34
vs -0.34

Q4.22

-53%

-0.53
vs -0.34

Q1.23

-132%

-1.32
vs -0.53

Q2.23

+338%

3.38
vs -1.32

Q3.23

-400%

-4.00
vs 3.38

Q4.23

+157%

1.57
vs -4.00

Q1.24

+77%

0.77
vs 1.57

Q2.24

+50%

0.5
vs 0.77

Institutionnal Ownership

QoQ

Q3.22

4
vs 4

Q4.22

4
vs 4

Q1.23

4
vs 4

Q2.23

5
vs 4

25%

Q3.23

6
vs 5

20%

Q4.23

3
vs 6

-50%

Q1.24

4
vs 3

33%

Q2.24

4
vs 4

Company Description

Infinityx

0.00x

-14.31x

-0.0

0.0%

$-0.9

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!